Commonly used drugs can quicken cognitive decline in elderly, reports say

Anticholinergics - a group of drugs commonly prescribed to treat conditions such as Parkinson's disease, urinary incontinence and acid reflux - may cause a more rapid decline in cognitive function among the elderly than previously thought, according to investigators.

Two new studies from the Wake Forest University's school of medicine show that not only do the drugs diminish mental capacity, they also have an impact on physical performance.

Anticholinergics are pharmacological opposites to cholinesterase inhibitors, a group of drugs used to treat dementia, which could lead to reduced effectiveness of one or both of the drugs, lead author Kaycee M. Sink said.

Of more than 3,500 seniors studied, those who took anticholinergics functioned more slowly and needed more assistance with activities of daily living than those who did not take the drugs. Sink likened their diminished physical abilities to those of someone three to four years older.

In a separate report published recently in the Journal of the American Geriatrics Society, Sink discovered that Alzheimer's patients who were taking some form of anticholinergics to treat incontinence had a 50% faster rate of mental decline than Alzheimer's patients who were only being treated for dementia.

Results of the first study were presented Saturday at the American Geriatrics Society annual meeting in Washington.

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.